Use of this site and material contained on its pages is for EDUCATIONAL USE ONLY.
 
Ceptic Online - View Patient Profiles

LeBlanc, Remi
MRN: 283714 Room: Exam #1 DOB: 2/17/2001 Age: 24 Gender: Female Allergies: NKDA, dust mite antigen
 Admit Notes
 Clinical Notes
 Vitals
 Labs, Cultures, Imaging
 Clinical Calculators
 MAR
 Current Orders
 Home Med List
 Med Reconciliation
 Discharge Planning
Setting Outpatient Internal Medicine Asthma Clinic
Scenario Patient was referred to the internal medicine asthma clinic for a follow-up evaluation of asthma therapy.
Admission note taken on 10/19/25
CC tired to due frequent awakenings, dark circles under the eyes
HPI RL was first diagnosed with asthma a little over one year ago just prior to starting college. She was admitted 2 months ago to the emergency department for an acute asthma exacerbation (her first) where she was treated with oral prednisone and albuterol. She was released from the emergency room after two hours of therapy with a five-day course of oral prednisone, as needed albuterol and a prescription for inhaled fluticasone. She followed up with her primary care physician on last month and at that time, she was given a peak flow monitor and told to monitor her peak expiratory flow rate every morning. She returned to her primary care physician for follow-up one month later with no improvement in peak expiratory flow rate and was referred to the internal medicine asthma clinic for evaluation. In clinic today, she has no specific complaints, but does state that she wakes up 2-3 times a week at night trying to catch her breath. She has been using her albuterol one to two times a day because it makes her feel better.
PMH
  • Allergic Rhinitis for 12 years
  • Gastroesophageal Reflux Disease for 4 years
  • Hypertension for 2 years
  • Asthma for 1 year
Social
History
  • Tobacco: Denies
  • ETOH: Denies
  • Illicit Drugs: Denies
  • Caffeine: 2-4 diet cokes per day
  • Occupation: College student
  • Status: Single
  • Children: none
  • Physical Activity: Somewhat limited due to shortness of breath with exercise
  • Diet: No limits, eats what she wants.
  • Living arrangements: Lives alone in a two bedroom wood frame house on a concrete slab. The patient does not have any pets.
Family
History
  • Father: Age 49 (Living), Hypertension, Dyslipidemia, Allergic Rhinitis, Obesity
  • Mother: Age 48 (Living), Depression
  • Sister: Age 18, (Living), Allergic Rhinitis
Vaccine
History
  • None
Surgical
History
  • None
Physical Exam
  • General: Female patient who looks her age and is in no apparent distress. She appears tired and has allergic shiners.
  • Skin: Normal
  • HEENT: Pupils equally round, 4.5mm, reactive to light and accommodation. Tympanic membranes are intact. Nasal mucous membranes are pale and swollen with no epistaxis. No nasal polyps. There is no tenderness over the frontal and maxillary sinuses, and the throat is normal.
  • Neck: Normal, no lymphadenopathy or thyromegaly.
  • Chest: slight bilateral wheezes scattered over all lung fields, no rales or rhonchi.
  • Breast: Deferred
  • Heart: Regular rate and rhythm, no gallops, murmur or rub
  • Abdomen: Soft, non-tender, bowel sounds (+)
  • Genitourinary/Rectal: Deferred
  • Extremities: No clubbing, cyanosis or edema, pulses 2 plus throughout.
  • Neurologic: Alert and oriented to person, place and time. Cranial nerves II-XII intact, deep tendon reflexes 2 plus throughout.
Clinical Laboratory Report
 
Test Name 10/19/2508/20/25 Range
Sodium (Na+) 141140 136-145 mEq/L
Potassium (K+) 4.13.6 3.5-5 mEq/L
Chloride (Cl-) 101103 98-106 mEq/L
Bicarbonate (HCO3-) 2428 23-28 mEq/L
Urea nitrogen (BUN) 1216 8-20 mg/dL
Creatinine 0.80.7 0.5-1.3 mg/dL
Glucose 8982 70-115 mg/dL
Hemoglobin A1c 5.85.7 5.3-7.5 %
Calcium,Total 8.78.9 8.6-10.2 mg/dL
Phosphate 3.63.8 3-4.5 mg/dL
Magnesium 1.61.5 1.6-2.6 mEq/L
Protein, total 6.97.1 5.5-9 g/dL
Albumin 4.44.3 3.5-5.5 g/dL
Aminotransferase,aspartate (AST) 2421 10-40 units/L
Aminotransferase,alanine (ALT) 2624 10-40 units/L
Lactic dehydrogenase (LDH) 10399 80-225 units/L
Alkaline phosphatase 5255 30-120 units/L
Bilirubin, Total 0.50.4 0.3-1 mg/dL
Leukocytes (WBC) 5.65.9 4.5-11 x103/mcL
Red blood cells (RBC), Female4.84.84.3-5.7 x108/mcL
Hemoglobin, Female14.714.912-16 g/dL
Hematocrit, Female40.64237-47 %
Mean corpuscular hemoglobin (MCH) 3133 27-33 picogram
Mean corpuscular volume (MCV) 8387 76-100 mcm3
Platelets 214225 150-450 x103/mcL
International normalized ratio (INR) 1.01.1 0.8-1.2
Prothrombin time (PT) 10.410.6 9.5-11.3 sec
Partial thromboplastin time,activated (aPTT) 3131 25-35 sec

 
 
Additional Labs:
Date
PEFR (L/min)
% predicted
FEV1
% predicted
FVC
FEV1/FVC ratio
Today
259
67
1.59
63
2.48
0.64
2 weeks ago
283
73
1 mo. ago
321
83
2 mo. ago (ED)
163
42
Cultures:
  • None
Imaging Studies: X-ray (2 mo. ago)
  • Clear in all fields, some flattening of the diaphragm.
Vital Sign 10/19/25
09:18
08/20/25
08:37
Height (cm) 155155
Weight (kg) 5557
Body Temperature (°C) 3737.2
Blood Pressure (mmHg) 138 / 88132/92
Heart Rate (bpm) 9488
Respiratory Rate (bpm) 1920
Oxygen Saturation (%) 9194
Current Orders
 
Medication
History
  • Singulair 10mg, 1 tablet by mouth daily, used for 1 year, stopped at ED visit (2 mo. ago) and Flovent started
  • Allegra D, 1 tablet by mouth daily, used for 1 month, changed to cetirizine (5 mo. ago) due to concerns over blood pressure

 
Home Medication List: verified by pharmacy on admit (10/19/25)
 
Patient Name: LeBlanc, Remi
Date of Birth: 2/17/2001
Room#: Exam #1
Allergies:
Immunization History:
Community Rx Info:
 
Rx Insurance:
Social History:
Additional Notes:
DRUG
STRENGTH
DF
STRENGTH
ROUTE
FREQ
PRN?
LAST
DOSE
(date/time)
ADVERSE
EFFECTS
ADHERENCE
NOTES
MED REC
ACTION
MED REC
REASON
Action Key:
C = Continue, D = Discontinue*, H = Hold*, M = Modify*
*must provide reason

                    
Medication 10/19/25
Clinical Notes
 
                    
Medication Discharge Orders
 
Hospital Medications
Medication Instructions Comments Continue Modify Discontinue New Rx sent

 
Previous Home Medications
Medication Instructions Comments Continue Modify Discontinue New Rx sent

 
 
Discharge Planning - Medication List and Instructions
 
Patient Name:
Admission Date: Discharge Date: Service:
Principle Diagnosis on Admission:
Secondary Diagnosis:
Allergies:

 
Medications ADDED this visit:
(begin taking these)
Medications CHANGED this visit:
(modify what you were taking)
Medications STOPPED this visit:
(stop taking these)

 
Final Discharge Medication List
Medication/Route/Dosage/Frequency/Duration Comments Morning Afternoon Evening Bedtime
As Needed Medications

 
          
Medication Reconciliation - Finalized Medication List
 
Patient Name: LeBlanc, Remi Date of Birth: 2/17/2001 Room: Exam #1

 
Medication (name/strength) Dose Route Frequency Notes